Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease Trial Phase 1 Completed Oct. 20, 2016
Evaluation of Nalmefene in Impulse Control Disorders in Parkinson's Disease: A Prospective Open Label Study Trial Phase 2 Unknown Oct. 16, 2016
Evaluate the Safety and Effectiveness of Various Frequency Stimulation for Patients With Parkinson's Disease Trial Phase 2 Unknown Oct. 12, 2016
Impact of Subthalamic Nucleus Deep Brain Stimulation on Pain in Parkinson Disease Trial N/A Completed Oct. 12, 2016
A Post Marketing Observational Study of Activities of Daily Living in Advanced Parkinson's Disease Patients With Early Troublesome Motor Fluctuations and Treated With Duodopa - a Multi-country Study Trial N/A Completed Oct. 12, 2016
Satisfaction Survey on PINS Stimulator System for Patients With Parkinson's Disease Trial N/A Unknown Oct. 12, 2016
Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease Patients Trial Phase 2 Completed Oct. 10, 2016
Physiopathological Study of Autonomic Failure in Parkinson's Disease Trial N/A Completed Oct. 4, 2016
Prospective Evaluation of Forceplate Measured Levodopa-Induced Dyskinesia Trial N/A Completed Sept. 29, 2016
A Phase I, Double Blind, Placebo Controlled, First in Human, Single and Multiple Ascending Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Male and Female Subjects Trial Phase 1 Completed Sept. 27, 2016
A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation Trial Phase 2 Terminated Sept. 22, 2016